February 10, 2014 / 4:41 PM / 4 years ago

BRIEF-Vectura receives Norwegian approval for Airflusal Forspiro

Feb 10 (Reuters) - Vectura Group PLC : * Norwegian regulatory authority confirm approval of airflusal forspiro * Treatment is new inhaler for patients with asthma and chronic obstructive

pulmonary disease (copd). * Source text

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below